Archives

The BGL Healthcare & Life Sciences Insider — Cardiology Investment Poised to Accelerate

The BGL Healthcare _ Life Sciences Insider -- Cardiology Investment Poised to Accelerate copy logo/IT Digest
The BGL Healthcare _ Life Sciences Insider -- Cardiology Investment Poised to Accelerate copy logo/IT Digest

The investment community is moving “up the acuity curve” as they seek novel opportunities to deploy capital, with Cardiology a specialty ripe for consolidation, according to an industry report released by the Healthcare Provider Services investment banking team at Brown Gibbons Lang & Company (BGL). Favorable secular trends, fragmentation, and the opportunity for platform growth through practice consolidation and service line expansion are draws.

Also Read: E-Prescriptions: The New Normal for the Healthcare Industry

Inside the report, BGL highlights a number of growth catalysts driving outside capital investment in the specialty:

Demographic trends that support sustained demand for cardiovascular care;
Regulatory tailwinds driving ongoing shift in site-of-service to the ambulatory environment, with reimbursement trends incentivizing such shifts;
Continued technological advancements facilitating delivery of advanced procedures in the outpatient setting, coupled with preventive trends like remote patient monitoring; and
Market fragmentation lending to consolidation opportunities.
The report also features an exclusive executive roundtable which discusses the current state of the market, as well as future outlook.

Dave Alpern, founding partner of Varsity Healthcare Partners, an investor in Partners First Cardiology, spoke to the attractiveness of cardiovascular services as an investment area: “Cardiology is a ripe category for investment. First, it’s a big space – 30,000-plus licensed cardiology providers in the U.S., where the hospital systems have been the only source of capital in cardiovascular medicine and currently roughly 70% of that population is employed by a hospital. Secondly, the secular trends in the cardiology/cardiovascular space are just undeniably good… along with what feels like sustainable Medicare support for reimbursement of cardiac interventions in the ambulatory environment … there’s a strong investment thesis there.” Alpern characterizes the recent approvals by Medicare for outpatient reimbursement in cardiology as the catalyst… “that will/is driving an outmigration of procedures from the hospital.

About Brown Gibbons Lang & Company
Brown Gibbons Lang & Company (BGL) is a leading independent investment bank and financial advisory firm focused on the global middle market